Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.64 |
| ▸ | GLP1R | P43220 | 8/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.56 |
| ▸ | CASP2 | P42575 | 1/20 | 0.56 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.52 |
| ▸ | ALB | P02768 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13057104 | 0.97 | NOD1 (0.67) | NOD1GLP1REPHX2SLC6A5ALB | |
| SCHEMBL23452088 | 0.95 | NOD1 (0.61) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL13057100 | 0.95 | NOD1 (0.61) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL18889448 | 0.94 | NOD1 (0.73) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL32679724 | 0.94 | NOD1 (0.60) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL9517919 | 0.93 | NOD1 (0.74) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL14937066 | 0.91 | NOD1 (0.76) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL14937344 | 0.91 | NOD1 (0.76) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL13855525 | 0.91 | NOD1 (0.76) | NOD1GLP1REPHX2CASP2SLC6A5 | |
| SCHEMBL13855526 | 0.91 | NOD1 (0.76) | NOD1GLP1REPHX2CASP2SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022115799-A1 | RADIOPHARMACEUTICAL CONJUGATES TARGETING GUANYLYL CYCLASE C, AND COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. (US) | 2022-06-02 | — | — | WO | disclosed |